Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1201149

NALTREXONE HYDROCHLORIDE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
Cl.O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5

Basic Information

ChEMBL ID CHEMBL1201149
Name NALTREXONE HYDROCHLORIDE
Phase Approved
Structure Type MOL
InChI Key RHBRMCOKKKZVRY-ITLPAZOVSA-N
Therapeutic ✓ Yes
Parent Compound CHEMBL19019
Active Moiety CHEMBL19019

Known Names

Adepend Depade EN-1639A EN-1639A (AS HYDROCHLORIDE) Nalorex Naltrexone hcl Naltrexone hydrochloride Naltrexone hydrochloride component of contrave Naltrexone hydrochloride component of embeda Naltrexone hydrochloride component of troxyca Opizone Revia +1 more
3
Targets
4
Activities
1
Assay Types
6
PK Parameters
20
Publications
13
Known Names
9
Indications
1
Mechanisms

Molecular Properties

341.4
MW (Da)
1.53
ALogP
5
HBA
2
HBD
70.0
PSA (Ų)
0.85
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1984
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral

Flags

Black Box Warning
USAN Stem nal-

Extended Properties

Molecular Formula C20H24ClNO4
MW 377.87
Aromatic Rings 1
Heavy Atoms 25
NP-Likeness 1.72

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Opioid receptors; mu/kappa/delta antagonist ANTAGONIST Opioid receptors; mu/kappa/delta

Indications

Pain Charcot-Marie-Tooth Disease Chronic Pain Self-Injurious Behavior Amphetamine-Related Disorders Feeding and Eating Disorders Opioid-Related Disorders Opioid-Related Disorders Severe Acute Respiratory Syndrome

Drug Warnings

Black Box Warning
General Warning
Country: United States

Activity Summary

IC50 4 meas. best 9.26

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Opioid receptors; mu/kappa/delta
CHEMBL2095181
IC50 9.26 9.245 0.6 2
Kappa-type opioid receptor
CHEMBL237
IC50 6.76 6.76 174.0 1
Plasmodium falciparum
CHEMBL364
IC50 4.9 4.9 12589.2 1

Pharmacokinetic Data

Parameter Value Units Species
Ke 5.5 nM Cavia porcellus
Ke 1.0 nM Cavia porcellus
Ke 24.0 nM -
Ke 37.0 nM Cavia porcellus
Ke 1.2 nM Cavia porcellus
Ke 69.0 nM -

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL5058564 U2OS 8
1849995 10.1021/jm00108a008 Mu-type opioid receptor 4
1849995 10.1021/jm00108a008 Delta-type opioid receptor 4
1849995 10.1021/jm00108a008 Kappa-type opioid receptor 4
- 10.6019/CHEMBL5058564 Fibroblast 4
894682 10.1021/jm00218a023 Opioid receptors; mu/kappa/delta 3
- 10.6019/CHEMBL5209801 N-formyl peptide receptor 2 2
- 10.6019/CHEMBL5209801 Adhesion G-protein coupled receptor F1 2
- 10.6019/CHEMBL5209801 Free fatty acid receptor 4 2
- 10.6019/CHEMBL5209801 C5a anaphylatoxin chemotactic receptor 1 2
1849995 10.1021/jm00108a008 Opioid receptors; delta & kappa 2
- 10.6019/CHEMBL5209801 Apelin receptor 2
- 10.6019/CHEMBL4495565 SARS-CoV-2 2
- 10.6019/CHEMBL5209801 Glucagon-like peptide 1 receptor 2
- 10.6019/CHEMBL5209801 CX3C chemokine receptor 1 2
1849995 10.1021/jm00108a008 Opioid receptors; mu & kappa 2
- 10.6019/CHEMBL5209801 Sphingosine 1-phosphate receptor 1 2
- 10.6019/CHEMBL5209801 Type-1 angiotensin II receptor 2
- 10.6019/CHEMBL5058564 HEK-293T 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2

Data from ChEMBL 36 via Core Engine